Menu
cmo-banner
Notch Left
Notch Right

Contract Manufacturing – A Win-Win Strategy

Harman Finochem undertakes custom manufacturing of APIs and advanced Intermediates by offering the pharmaceutical industry a new approach for outsourcing services with a dedicated focus on enhancing value and competitive advantage to its customers over the entire life cycle of the products.

international regulatory authorities

USFDA

USFDA

EDQM

EDQM

Australian TGA

Australian TGA

Taiwan FDA

Taiwan FDA

Chinese FDA

Chinese FDA

BENEFITS TO CUSTOMERS

Extend your hand towards a fruitful partnership

USFDA

Partnership with Harman will not only enable customers to free their existing production capacities but will also allow them to expand their technical resources without increasing their overheads for new projects.

Bring new products to market faster with higher margins

EDQM

By concentrating resources with a single-source provider, our customers can minimize technical transfer of projects or products, thereby reducing unforeseen costs and potentially speeding new products to market.

Focus on your strengths to create competitive advantages

USFDA

Customers can manage their internal resources and costs by focusing on core competencies and high-value projects while reducing or not adding infrastructure or technical staff.

Let us help you minimize your project cost!

EDQM

Working with Harman will also limit our customers upfront capital investment for drug development, thus minimizing a project’s cost.